Commercially Supported Symposia (CSS)

Join your fellow colleagues during the AAPM 35th Annual Meeting & Preconferences in Denver at Commercially Supported Symposia (CSS) and expand your knowledge in pain management. Attend these CSS to gain comprehensive insight into important topics and issues facing today’s pain specialists. This year we are offering both CME-certified and non-CME-certified symposia. CSS descriptions for certified activities, faculty disclosures, and procedures for obtaining CME credit will be provided by individual organizers.

Registration is not required; however, seating is limited for all events. We recommend arriving at the event early. Breakfast or lunch sponsored by AAPM will be provided prior to each CSS. There are no fees to attend any of these CSS. Nonmedical professionals or members of industry may only be allowed to participate at the discretion of the CSS sponsoring company.

Noon–1:30 pm Thursday, March 7

Lunch CME Satellite Symposia

Agenda

Noon-12:30 pm

AAPM Lunch Provided

12:30-1:30 pm

Recognition and Management of Migraine in an Era of Expanding Options for Acute Treatment and Prevention

Educational Objectives

  • Apply established screening tools and criteria for migraine diagnosis in clinical practice.
  • Identify data on the efficacy, safety, and tolerability of established and emerging therapeutics for the acute treatment of migraine.
  • Cite updated evidence on available and emerging therapies for the prevention of migraine.
  • Employ strategies to integrate emerging therapies for acute treatment and headache prevention into personalized management plans for patients with migraine if/when these agents are approved in the future.

Description

Migraine, a common neurovascular brain disorder, represents a severe and widespread health problem. In recent years a number of novel therapies for the acute treatment and prevention of migraine have been developed. These include centrally acting serotonin (5HT1F) agonists and therapies directed against the calcitonin gene-related peptide (CGRP) ligand and its receptor. During this PeerView Live lunch symposium, after briefly reviewing how migraine can be identified in clinical practice, experts in the management of this neurologic disorder will discuss the latest data on emerging therapies for the acute treatment of migraine, assess current data on approved and emerging anti-CGRP monoclonal antibodies for migraine prevention, and highlight key considerations for using these therapies in clinical practice.

Register now.

 

Read more...
Speakers:

Stewart J. Tepper, MD, FAHS

Robert P. Cowan, MD, FAAN, FAHS

Noon–1:30 pm Friday, March 8

Lunch Non-CME Satellite Symposia

Agenda

Noon-12:30 pm

AAPM Lunch Provided

12:30-1:30 pm

The Long Lasting Impact of a Short Conversation About Opioid Overdose Risks

Educational Objectives

After attending this symposium, participants should be better able to:

  • Identify patients at risk for an opioid overdose.
  • Facilitate brief and impactful conversations with patients and care partners around risk of opioid overdose and the need for take-home naloxone.
  • Implement strategies to incorporate communication about opioid overdose and take-home naloxone into clinical protocols when prescribing opioids.

Description

Despite mounting concern and efforts to address opioid overdose in the United States, death rates involving prescription opioids have not abated. This statistic highlights missed opportunities for clinicians to intervene to help save lives. Numerous government agencies and professional organizations recommend that clinicians co-prescribe take-home naloxone with opioids for at-risk patients as a precaution to help prevent opioid overdose deaths. While it is necessary to first identify patients at risk of an opioid overdose, just as important is engaging in conversations that can help save patients’ lives. The faculty will model a brief and impactful conversation with patients and care partners in a way that facilitates patient acceptance to take-home naloxone being part of their chronic pain treatment plan.

Please see Important Safety Information and full Prescribing Information.

Read more...
Noon–1:30 pm Friday, March 8

Lunch Non-CME Satellite Symposia

Agenda

Noon-12:30 pm

AAPM Lunch Provided

12:30-1:30 pm

Opioid Therapy Insights: A Holistic Approach to Managing Patients

Description

In this interactive, industry-sponsored presentation, we will discuss when to consider an abuse-deterrent opioid for chronic pain. We will also explore treatment options for opioid-induced constipation in adult patients with chronic non-cancer pain.

Activity sponsored by Daiichi Sankyo, Inc. & Inspirion Delivery Sciences

Read more...
12:15–1:45 pm Saturday, March 9

Lunch Non-CME Satellite Symposia

Agenda

12:15-12:45 pm

AAPM Lunch Provided

12:45-1:45 pm

Alternative Options to the Management of Chronic Pain

Description

To review and discuss the unique pharmacologic properties, clinical efficacy, and use of an alternative option for the management of chronic pain.

Activity sponsored by BioDelivery Sciences International, Inc.

Read more...
Subscribe to this RSS feed